| Roy A Kaplan, MD | |
|
345 Saxony Rd, Suite 105, Encinitas, CA 92024-2787 | |
| (760) 753-7374 | |
| (760) 753-0110 |
| Full Name | Roy A Kaplan |
|---|---|
| Gender | Male |
| Speciality | Internal Medicine - Rheumatology |
| Location | 345 Saxony Rd, Encinitas, California |
| Accepts Medicare Assignments | Does not participate in Medicare Program. He may not accept medicare assignment. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1215962451 | NPI | - | NPPES |
| 00G318591 | Medicaid | CA |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 207RR0500X | Internal Medicine - Rheumatology | G31859 (California) | Primary |
| Mailing Address | Practice Location Address |
|---|---|
| Roy A Kaplan, MD 345 Saxony Rd, Suite 105, Encinitas, CA 92024-2787 Ph: (760) 753-7374 | Roy A Kaplan, MD 345 Saxony Rd, Suite 105, Encinitas, CA 92024-2787 Ph: (760) 753-7374 |
News Archive
A new study released today shows that among patients undergoing surgery for chronic wounds related to diabetes, the risk of wound-related complications is affected by how well the patient's blood sugar levels are controlled before surgery. These findings appear in the October issue of Plastic and Reconstructive Surgery, the official medical journal of the American Society of Plastic Surgeons.
Researchers at the University of Pennsylvania School of Medicine have discovered a molecular circuit involving heme that helps maintain proper metabolism in the body, providing new insights into metabolic disorders such as obesity and diabetes.
In Ethiopia, where more than 1.2 million people are infected with HIV, disclosure of infection by patients is important in the fight against the disease. A new study led by a Brown sociology researcher investigates HIV-positive status disclosure rates among men and women in Africa's second most populous country.
Genervon Biopharmaceuticals announced today that the U.S. Food and Drug Administration has granted an "orphan drug" designation to Genervon's GM604 (a.k.a. GM6) bio-drug for the treatment of Amyotrophic Lateral Sclerosis (ALS). The FDA also granted GM604 a "fast-track" designation for ALS in 2013.
› Verified 7 days ago
Alberto Bessudo, M.D. Rheumatology Medicare: Accepting Medicare Assignments Practice Location: 326 Santa Fe Dr Ste 105, Encinitas, CA 92024 Phone: 760-452-3340 Fax: 760-452-3344 | |
Dr. Gordon L. Kim, M.D. Rheumatology Medicare: Accepting Medicare Assignments Practice Location: 326 Santa Fe Dr, Encinitas, CA 92024 Phone: 760-753-5594 | |
Dr. Wesley Shih, M.D. Rheumatology Medicare: Accepting Medicare Assignments Practice Location: 354 Santa Fe Dr, Encinitas, CA 92024 Phone: 760-230-2251 Fax: 760-230-2253 | |
Batyrjan Bulibek, M.D. Rheumatology Medicare: Accepting Medicare Assignments Practice Location: 320 Santa Fe Dr Ste 204, Encinitas, CA 92024 Phone: 760-944-7300 Fax: 760-633-3949 | |
Dr. Gay Mcmanus Walker, M.D. Rheumatology Medicare: Accepting Medicare Assignments Practice Location: 477 N El Camino Real, Suite 208a, Encinitas, CA 92024 Phone: 760-479-3900 Fax: 760-479-3923 | |
Dr. Richard Michael Jacoby, MD Rheumatology Medicare: May Accept Medicare Assignments Practice Location: 700 Garden View Ct Ste 204, Encinitas, CA 92024 Phone: 760-452-6334 Fax: 760-349-9755 | |
Dr. Anjali Anil Bharne, M.D Rheumatology Medicare: Accepting Medicare Assignments Practice Location: 1200 Garden View Rd, Suite 200, Encinitas, CA 92024 Phone: 760-536-7700 Fax: 760-536-7710 |